B. SCHARLING

438 total citations
11 papers, 363 citations indexed

About

B. SCHARLING is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Physiology. According to data from OpenAlex, B. SCHARLING has authored 11 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Hematology and 3 papers in Physiology. Recurrent topics in B. SCHARLING's work include Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). B. SCHARLING is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). B. SCHARLING collaborates with scholars based in Denmark, Germany and Iran. B. SCHARLING's co-authors include Tal Engel, J. H. Heinig, Flemming Madsen, H.‐J. Malling, Kurt Nikander, Per Damkier, K. Br�sen, Judi Møss, Mirella Ezban and Tine Møller Sørensen and has published in prestigious journals such as Journal of Thrombosis and Haemostasis, Allergy and British Journal of Clinical Pharmacology.

In The Last Decade

B. SCHARLING

11 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. SCHARLING Denmark 10 165 120 116 54 43 11 363
K. Hama Japan 12 56 0.3× 36 0.3× 16 0.1× 15 0.3× 23 0.5× 34 523
Cesar Rudzki United States 7 42 0.3× 64 0.5× 22 0.2× 70 1.3× 51 1.2× 10 309
Mark Veerman United States 7 120 0.7× 67 0.6× 46 0.4× 4 0.1× 8 0.2× 10 368
Chise Kodaira Japan 18 231 1.4× 11 0.1× 13 0.1× 40 0.7× 64 1.5× 41 778
G Riedler Switzerland 6 59 0.4× 22 0.2× 52 0.4× 13 0.2× 10 0.2× 12 298
Robert Slade United Kingdom 10 35 0.2× 17 0.1× 40 0.3× 9 0.2× 58 1.3× 20 244
D. Kampf Germany 10 53 0.3× 25 0.2× 31 0.3× 15 0.3× 14 0.3× 31 248
Pierre Reding Belgium 7 31 0.2× 37 0.3× 13 0.1× 26 0.5× 21 0.5× 18 317
Rajiv Kumar India 9 22 0.1× 18 0.1× 130 1.1× 9 0.2× 33 0.8× 39 297

Countries citing papers authored by B. SCHARLING

Since Specialization
Citations

This map shows the geographic impact of B. SCHARLING's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. SCHARLING with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. SCHARLING more than expected).

Fields of papers citing papers by B. SCHARLING

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. SCHARLING. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. SCHARLING. The network helps show where B. SCHARLING may publish in the future.

Co-authorship network of co-authors of B. SCHARLING

This figure shows the co-authorship network connecting the top 25 collaborators of B. SCHARLING. A scholar is included among the top collaborators of B. SCHARLING based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. SCHARLING. B. SCHARLING is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Morfini, Massimo, Víctor Jiménez‐Yuste, Hermann Eichler, et al.. (2011). Pharmacokinetic properties of two different recombinant activated factor VII formulations. Haemophilia. 18(3). 431–436. 6 indexed citations
2.
Møss, Judi, B. SCHARLING, Mirella Ezban, & Tine Møller Sørensen. (2008). Evaluation of the safety and pharmacokinetics of a fast‐acting recombinant FVIIa analogue, NN1731, in healthy male subjects. Journal of Thrombosis and Haemostasis. 7(2). 299–305. 38 indexed citations
3.
Lak, Muhammad Ali, B. SCHARLING, Allan Blemings, et al.. (2007). Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia. 14(1). 103–110. 32 indexed citations
4.
5.
6.
Damkier, Per, et al.. (2004). Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide. European Journal of Clinical Pharmacology. 60(2). 109–114. 70 indexed citations
7.
Kapitza, Christoph, Marcus Hompesch, B. SCHARLING, & Tim Heise. (2004). Intrasubject Variability of Inhaled Insulin in Type 1 Diabetes: A Comparison with Subcutaneous Insulin. Diabetes Technology & Therapeutics. 6(4). 466–472. 20 indexed citations
8.
Frølund, L., Flemming Madsen, B. SCHARLING, J. H. Heinig, & U. G. Svendsen. (1992). Bronchial allergen challenge: dose versus concentration. Clinical & Experimental Allergy. 22(2). 219–225. 10 indexed citations
9.
Eiken, Pia, Holger Mosbech, Lars Jacobsen, et al.. (1992). Comparison between two different assays for measurements of allergen‐specific IgE and skin prick test in the diagnosis of insect venom allergy. Allergy. 47(5). 495–497. 11 indexed citations
10.
11.
Engel, Tal, J. H. Heinig, H.‐J. Malling, et al.. (1989). Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler®. Allergy. 44(3). 220–225. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Hama Breakdown of academic impact, for papers by Cesar Rudzki Breakdown of academic impact, for papers by Mark Veerman Breakdown of academic impact, for papers by Chise Kodaira Breakdown of academic impact, for papers by G Riedler Breakdown of academic impact, for papers by Robert Slade Breakdown of academic impact, for papers by D. Kampf Breakdown of academic impact, for papers by Pierre Reding Breakdown of academic impact, for papers by Rajiv Kumar
Rankless by CCL
2026